Anti-abortion groups shrug off election losses, look to courts, statehouses for path forward

Il­lu­mi­na and Grail are an­oth­er step clos­er to end­ing their years­long an­titrust saga. The Eu­ro­pean Com­mis­sion has ap­proved Il­lu­mi­na’s di­vest­ment plan for Grail, the can­cer

The post-SPAC life isn’t all too great for most biotech com­pa­nies — or those in oth­er in­dus­tries, for that mat­ter. But some drug de­vel­op­ers that